Laxxon Medical | WebDisclosure

Basculer en Français

11143	Companies
245554	Keywords
173598	Articles
132485	Press releases

Home
Companies
Laxxon Medical

PRESS RELEASE

published on 10/14/2024 at 16:00, 1 year 11 months ago

Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention
Laxxon Medical to showcase innovative oral GLP-1 Agonist micro-tablet at 2024 BIO Europe Convention, aiming to enhance patient compliance. Event aims to discover new partnerships

Laxxon Medical Oral GLP-1 Agonist Patient Compliance Micro-tablet BIO Europe Convention
BRIEF

published on 10/09/2024 at 20:06, 1 year 11 months ago

Laxxon Medical to Present SPID® Technology at CPHI Milan 2024

Laxxon Medical Pharmaceutical Manufacturing SPID® Technology CGMP Printing Technology CPHI Milan 2024
BRIEF

published on 10/09/2024 at 20:06, 1 year 11 months ago

Laxxon Medical présentera la technologie SPID® au CPHI Milan 2024

Laxxon Medical Fabrication Pharmaceutique Technologie SPID® CPHI Milan 2024 Technologie D'impression CGMP
PRESS RELEASE

published on 10/09/2024 at 20:01, 1 year 11 months ago

Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
Laxxon Medical to showcase cGMP Printing Technology at CPHI Milan 2024, unveiling innovative oral drug delivery systems through SPID® Technology

Laxxon Medical SPID® Technology CGMP Printing CPHI Milan Oral Drug Delivery
BRIEF

published on 10/01/2024 at 15:05, 2 years ago

Laxxon Medical et Adare Pharma Solutions annoncent une coopération conjointe pour la production de formes posologiques orales imprimées en 3D cGMP en Europe et aux États-Unis

Production CGMP Laxxon Medical Adare Pharma Partenariat Pharmaceutique Médicaments Imprimés En 3D
BRIEF

published on 10/01/2024 at 15:05, 2 years ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US

CGMP Production Laxxon Medical Pharma Partnership 3D Printed Drugs Adare Pharma
PRESS RELEASE

published on 10/01/2024 at 15:00, 2 years ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
Laxxon Medical & Adare Pharma Cooperate for cGMP 3D Printed Oral Dosage Forms production in Europe & US. Utilizing SPID® Technology by Laxxon & Adare's cGMP-certified facilities

Drug Delivery Laxxon Medical 3D Printed Adare Pharma Solutions CGMP
BRIEF

published on 05/22/2024 at 15:10, 2 years 4 months ago

Laxxon Medical annonce le développement d'un actif GLP-1 oral non invasif

Laxxon Medical Traitement De L'obésité Agoniste Du Récepteur GLP-1 Technologie SPID® Voie 505(b)2
BRIEF

published on 05/22/2024 at 15:10, 2 years 4 months ago

Laxxon Medical Announces Development of Non-Invasive Oral GLP-1 Asset

Obesity Treatment Laxxon Medical GLP-1 Receptor Agonist SPID® Technology 505(b)2 Pathway
PRESS RELEASE

published on 05/22/2024 at 15:05, 2 years 4 months ago

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Laxxon Medical announces development program for LXM.2, a 3D printed oral GLP-1 receptor agonist for obesity treatment, offering an alternative to injections. Utilizes SPID® platform technology for enhanced bioavailability

Obesity Treatment Laxxon Medical GLP-1 LXM.2 3D Printed

Accesswire

Published on 10/07/2026 at 15:30, 39 minutes ago

Gold Port Announces Marketing Agreement with NAI Interactive Ltd.
Published on 10/07/2026 at 14:30, 1 hour 39 minutes ago

Secure Blockchain's Agentic Solutions Signs Financial Services Firm, Expanding Enterprise AI Into Corporate Finance
Published on 10/07/2026 at 13:33, 2 hours 36 minutes ago

BULGOLD Samples 21.2g/t Gold at Surface and Expands Kopernica Footprint by 170% to 1,700 Metres by 800 Metres, Lutila Project
Published on 10/07/2026 at 13:00, 3 hours 9 minutes ago

ATHA Energy Successfully Completes Diamond Drilling at RIB North Discovery, Expanding Strike Length To 3.4 Km, And Identifies a Higher-Grade Sub Zone: Results Include RIBN-DD-023 Intersecting 19.5 M Of Composite Uranium Mineralization With 2.0 M Of High-G
Published on 10/07/2026 at 11:00, 5 hours 9 minutes ago

GMV Minerals Announces Assays from 2026 Diamond Drill Program including: 12.64 gpt Gold over 4.88 m in MHC26-14

View all ACCESSWIRE

EQS Group

Published on 10/07/2026 at 15:45, 24 minutes ago

EQS-Adhoc: VINCORION SE: VINCORION SE reports 41% higher revenue for the first 9 months of 2026 compared to the same period last year; Full-Year Guidance raised
Published on 10/07/2026 at 14:58, 1 hour 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/07/2026 at 14:58, 1 hour 11 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 10/07/2026 at 14:57, 1 hour 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 10/07/2026 at 14:56, 1 hour 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: easyJet plc

Les Echos

Published on 10/07/2026 at 15:54, 15 minutes ago

Disclosure of Share Capital and Voting Rights as of September 30, 2026
Published on 10/07/2026 at 15:54, 15 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 septembre 2026
Published on 10/07/2026 at 10:30, 5 hours 39 minutes ago

Déclaration mensuelle du nombre total de droits de vote et du nombre d’actions composant le capital
Published on 10/07/2026 at 10:17, 5 hours 52 minutes ago

Déclaration d'actions et de droits de vote au 30.09.2026
Published on 10/07/2026 at 08:15, 7 hours 54 minutes ago

EURAZEO TO ACQUIRE MIYA WATER, A GLOBAL SPECIALIST IN EFFICIENT WATER MANAGEMENT SOLUTIONS

View all LES ECHOS COMFI WIRE